MedTrace Logo

Soluble Triggering Receptor Expressed on Myeloid Cells in Severe Acute Pancreatitis

NCT01193413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2010-09-02

No results posted yet for this study

Summary

Early diagnosis of secondary infection of necrotic tissue in severe acute pancreatitis is extremely important. The investigators evaluated whether the level of soluble TREM-1 (sTREM-1) in fine needle aspiration (FNA) fluid from patients who suspected infection is a good marker of secondary infection of necrotic tissue and an indicator of the proper treatment between drainage and necrosectomy.

Conditions

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • zhaoshen li, MD · Changhai Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-07-31
Completion
2009-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193413 on ClinicalTrials.gov